Correlation Between Morgan Stanley and Seelos Therapeutics

Can any of the company-specific risk be diversified away by investing in both Morgan Stanley and Seelos Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Morgan Stanley and Seelos Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Morgan Stanley Direct and Seelos Therapeutics, you can compare the effects of market volatilities on Morgan Stanley and Seelos Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Morgan Stanley with a short position of Seelos Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Morgan Stanley and Seelos Therapeutics.

Diversification Opportunities for Morgan Stanley and Seelos Therapeutics

-0.81

Correlation Coefficient

Morgan Stanley  Seelos Therapeutics

Pay attention - limited upside

The 3 months correlation between Morgan and Seelos is -0.81. Overlapping area represents the amount of risk that can be diversified away by holding Morgan Stanley Direct and Seelos Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Seelos Therapeutics and Morgan Stanley is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Morgan Stanley Direct are associated (or correlated) with Seelos Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Seelos Therapeutics has no effect on the direction of Morgan Stanley i.e., Morgan Stanley and Seelos Therapeutics go up and down completely randomly.

Pair Corralation between Morgan Stanley and Seelos Therapeutics

Given the investment horizon of 90 days Morgan Stanley Direct is expected to generate 0.16 times more return on investment than Seelos Therapeutics. However, Morgan Stanley Direct is 6.2 times less risky than Seelos Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Seelos Therapeutics is currently generating about -0.14 per unit of risk. If you would invest  1,862  in Morgan Stanley Direct on October 7, 2024 and sell it today you would earn a total of  220.00  from holding Morgan Stanley Direct or generate 11.82% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	51.61%
Values	Daily Returns

Morgan Stanley Direct  vs.  Seelos Therapeutics

Morgan Stanley Direct

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Morgan Stanley Direct are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite quite weak fundamental indicators, Morgan Stanley may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Seelos Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Seelos Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's technical and fundamental indicators remain quite persistent which may send shares a bit higher in February 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Pair Trading with Morgan Stanley and Seelos Therapeutics

The main advantage of trading using opposite Morgan Stanley and Seelos Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Morgan Stanley position performs unexpectedly, Seelos Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Seelos Therapeutics will offset losses from the drop in Seelos Therapeutics' long position.

The idea behind Morgan Stanley Direct and Seelos Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.